Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Background: LINE-1s (L1, Long Interspersed Element-1) are the most abundant autonomous non-LTR retrotransposons in the human genome and replicate by reverse transcription of an RNA intermediate. Full-length L1 encodes two open reading frames (ORF1, ORF2) and ORF2 has reverse transcriptase activity. Results: Here we expressed human L1 RT in E. coli and the purified protein displayed the same RT activity as that of ORF2p expressed in insect cells. We tested the effect of different reverse transcriptase inhibitors on L1 RT and found that all four tested nucleoside inhibitors efficiently inhibited L1 RT activity competitively. The K i values of NRTIs were calculated (AZTTP, 16.4 ± 4.21 nM; d4TTP, 0.73 ± 0.22 nM; ddCTP, 0.72 ± 0.16 nM; 3TCTP, 12.9 ± 2.07 nM). L1 RT was less sensitive to non-nucleoside reverse transcriptase inhibitors, among these nevirapine had no effect, even at concentrations up to 500 μM. We also examined the effect of RT inhibitors on L1 retrotransposition efficiency in vivo using a cell-based retrotransposition assay. Similarly, all analog inhibitors decreased L1 retrotransposition frequency with different potencies whereas nevirapine had little or no effect on L1 retrotransposition. For comparison, we also tested the same inhibitors to highly purified RT of an LTR-retrotransposon (Ty1) and found it was less sensitive to NRTIs than L1 RT and has the same inhibition profile as L1 RT to NNRTIs. Conclusions: These data indicate that bacterially expressed L1 RT is an active reverse transcriptase sensitive to nucleoside RT inhibitors but not to non-nucleoside inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Kinetic analysis of inhibition of L1 RT by NRTIs. The L1 RT activity was measured as described in materials and methods. (A) Double reciprocal plot of the velocity of the L1 RT activity as a function of [32P]-dTTP substrate concentration. Increasing concentrations of substrate in the absence (diamond) or presence of 2 nM (square), 5 nM (triangle), 10 nM (circle) or 15 nM (+) AZTTP. (B) Double reciprocal plot of the velocity of the L1 RT activity as a function of [32P] dTTP substrate concentration. Increasing concentrations of substrate in the absence (diamond) or presence of 0.1 nM (square), 0.2 nM (triangle), 0.5 nM (circle) or 1 nM (+) d4TTP. (C) Double reciprocal plot of the velocity of the L1 RT activity as a function of [32P] dCTP substrate concentration. Increasing concentrations of substrate in the absence (diamond) or presence of 0.5 nM (square), 1 nM (triangle), 2 nM (circle) or 5 nM (+) ddCTP. (D) Double reciprocal plot of the velocity of the L1 RT activity as a function of [32P] dTTP substrate concentration. Increasing concentrations of substrate in the absence (diamond) or presence of 5 nM (square), 10 nM (triangle), 20 nM (circle) or 50 nM (+) 3TCTP.](https://figures.cochat.ai/paper-figures/055bef08b4f04b9584d98f1cc400977b/effect-of-reverse-transcriptase-inhibitors-on-line-1-and-ty1-reverse-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some NRTIs developed against HIV have been found to also inhibit L1 RT activity15.”
From L1 drives IFN in senescent cells and promotes age-associated inflammation (2019) · cites this paper as [15]
In the citing paper
“Consistent with this, another group showed that NRTIs effectively inhibit the reverse transcriptase activity of the L1 protein, ORF2p, consequently reducing retrotransposition (Dai et al., 2011).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Dai et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.4876 · Cited by 38,993
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition
Feng, Q., Moran, J. V., Kazazian, H. H., & Boeke, J. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81997-2 · Cited by 1,139 · cited 2×
“ORF2 encodes a ~150 kDa multifunctional protein (ORF2p) with endonuclease (EN) [17], reverse transcriptase (RT) activities [18-20] and a cysteine-rich domain of unknown function [21].”
BackgroundSelf-citationHot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073 · cited 1×
“Though most L1 copies are functionally inactive, there are ~80-100 retrotransposition-competent L1s in human genome [2].”
BackgroundLINE-mediated retrotransposition of marked Alu sequences
Dewannieux, M., Esnault, C., & Heidmann, T. (2003) · Nature Genetics · doi:10.1038/ng1223 · Cited by 1,023 · cited 1×
“L1s have greatly shaped the human genome by their own retrotransposition and mobilization of non-autonomous elements (Alu, SINEs) in trans [3-6].”
BackgroundHigh frequency retrotransposition in cultured mammalian cells
Moran, J. V., Holmes, S. E., Naas, T. P., DeBerardinis, R. J., Boeke, J. D., & Kazazian, H. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81998-4 · Cited by 1,022 · cited 2×
“The cell-based retrotransposition assay was conducted as described [26].”
BackgroundMethodSelf-citationHuman LINE retrotransposons generate processed pseudogenes
Esnault, C., Maestre, J., & Heidmann, T. (2000) · Nature Genetics · doi:10.1038/74184 · Cited by 830 · cited 1×
“L1s have greatly shaped the human genome by their own retrotransposition and mobilization of non-autonomous elements (Alu, SINEs) in trans [3-6].”
BackgroundReverse Transcriptase Encoded by a Human Transposable Element
Mathias, S. L., Scott, A. F., Kazazian, H. H., Boeke, J. D., & Gabriel, A. (1991) · Science · doi:10.1126/science.1722352 · Cited by 773 · cited 1×
“ORF2 encodes a ~150 kDa multifunctional protein (ORF2p) with endonuclease (EN) [17], reverse transcriptase (RT) activities [18-20] and a cysteine-rich domain of unknown function [21].”
BackgroundSelf-citationLander, E., Linton, L., Birren, B. W., & Nusbaum, C. (2001) · Cited by 772
Cited by
L1 drives IFN in senescent cells and promotes age-associated inflammation
De Cecco, M., Ito, T., Petrashen, A. P., Elias, A. E., Skvir, N. J., Criscione, S. W., Caligiana, A., Brocculi, G., Adney, E. M., Boeke, J. D., et al. (2019) · Nature · doi:10.1038/s41586-018-0784-9 · Cited by 1,255
“Some NRTIs developed against HIV have been found to also inhibit L1 RT activity 15 .”
Self-citationRoles for retrotransposon insertions in human disease
Hancks, D. C., & Kazazian, H. H. (2016) · Mobile DNA · doi:10.1186/s13100-016-0065-9 · Cited by 670
“Interestingly, nucleoside reverse-transcriptase inhibitors known to inhibit LINE-1 activity [230] can block RPE degeneration and inflammasome activation in mice injected sub-retinally with a plasmid expressing Alu [231].”
BackgroundInterventions to slow aging in humans: are we ready?
Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., Curiel, T. J., Cabo, R., Franceschi, C., Gems, D., et al. (2015) · Aging Cell · doi:10.1111/acel.12338 · Cited by 592
“Some nucleoside reverse transcriptase inhibitors currently used clinically to treat HIV infection, such as lamivudine or adefovir, block retrotransposition of several endogenous elements, including LINE1, the only known active retrotransposition family in human genomes (Dai et al. , 2011).”
LINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.014 · Cited by 498
“Several studies have reported that in addition to impeding the activity of viral polymerases, NRTIs such as 3TC and d4T, are also potent inhibitors of L1 RT (Dai et al., 2011; Jones et al., 2008).”
BackgroundThe quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Metadata
- Authors
- Dai, L., Huang, Q., & Boeke, J. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Boeke, Jef D
- Venue
- BMC Biochemistry
- Published
- 2011-05-05
- Volume
- 12
- Issue
- 1
- Pages
- 18-18
- ISSN
- 1471-2091 (ISSN-L)
- PMC
- PMC3103432
- OpenAlex
- W1982644994
- Cited by
- 131
- References
- 55
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 7 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 18 · 2019: 13 · 2018: 6 · 2017: 12 · 2016: 4 · 2015: 7 · 2014: 5 · 2013: 11 · 2012: 1
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- BMC Biochemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA16519, P01CA016519)
- National Institute of General Medical Sciences (R01-GM36481, R01GM036481)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- LINE-1 retrotransposons, reverse transcriptase inhibitors, retrotransposition, Ty1 retrotransposon, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, nevirapine, LTR retrotransposons, competitive inhibition, Ki values, non-LTR retrotransposons
- MeSH terms
- Amino Acid Sequence, Cell-Free System, Escherichia coli, HeLa Cells, Humans, Kinetics, Molecular Sequence Data, RNA-Directed DNA Polymerase, HIV-1, HIV-2, Reverse Transcriptase Inhibitors, Long Interspersed Nucleotide Elements, Enzyme Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition. https://app.cochat.ai/papers/10.1186/1471-2091-12-18
- The paper
- Dai, L., Huang, Q., & Boeke, J. D. (2011). Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition. BMC Biochemistry. https://doi.org/10.1186/1471-2091-12-18
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.